Clorox (NYSE:CLX) Price Target Cut to $151.00

Clorox (NYSE:CLX) had its price target dropped by investment analysts at Deutsche Bank Aktiengesellschaft from $155.00 to $151.00 in a research note issued to investors on Wednesday, Benzinga reports. The firm presently has a “hold” rating on the stock. Deutsche Bank Aktiengesellschaft’s price target would indicate a potential upside of 5.51% from the stock’s current price.

A number of other analysts have also recently issued reports on CLX. Jefferies Financial Group upgraded Clorox from an “underperform” rating to a “hold” rating and set a $145.00 price objective on the stock in a research report on Tuesday, March 26th. UBS Group upped their price target on Clorox from $145.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, February 2nd. Citigroup lowered their price target on Clorox from $165.00 to $155.00 and set a “neutral” rating on the stock in a research report on Tuesday. Barclays lowered their price target on Clorox from $148.00 to $136.00 and set an “underweight” rating on the stock in a research report on Wednesday, April 10th. Finally, JPMorgan Chase & Co. upped their price target on Clorox from $145.00 to $152.00 and gave the company a “neutral” rating in a research report on Thursday, January 18th. Four analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $148.63.

Clorox Stock Performance

Shares of NYSE CLX opened at $143.12 on Wednesday. The company has a quick ratio of 0.57, a current ratio of 0.89 and a debt-to-equity ratio of 11.37. The business’s 50 day moving average is $150.18 and its two-hundred day moving average is $141.70. The company has a market cap of $17.76 billion, a P/E ratio of 227.18, a P/E/G ratio of 2.22 and a beta of 0.43. Clorox has a 12 month low of $114.68 and a 12 month high of $178.21.

Clorox (NYSE:CLX) last released its quarterly earnings data on Thursday, February 1st. The company reported $2.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.08 by $1.08. The business had revenue of $1.99 billion for the quarter, compared to analysts’ expectations of $1.80 billion. Clorox had a return on equity of 319.41% and a net margin of 1.09%. Clorox’s quarterly revenue was up 16.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.98 earnings per share. On average, equities analysts expect that Clorox will post 5.52 EPS for the current year.

Hedge Funds Weigh In On Clorox

Several hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Clorox by 0.3% in the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after acquiring an additional 44,344 shares during the last quarter. BlackRock Inc. boosted its holdings in Clorox by 2.1% during the first quarter. BlackRock Inc. now owns 9,463,011 shares of the company’s stock worth $1,497,427,000 after buying an additional 195,348 shares during the last quarter. Geode Capital Management LLC boosted its holdings in Clorox by 3.8% during the first quarter. Geode Capital Management LLC now owns 2,725,410 shares of the company’s stock worth $430,349,000 after buying an additional 100,920 shares during the last quarter. FMR LLC boosted its holdings in Clorox by 17.4% during the third quarter. FMR LLC now owns 2,415,054 shares of the company’s stock worth $316,517,000 after buying an additional 357,964 shares during the last quarter. Finally, Stifel Financial Corp boosted its holdings in Clorox by 2.2% during the third quarter. Stifel Financial Corp now owns 2,184,875 shares of the company’s stock worth $286,356,000 after buying an additional 47,879 shares during the last quarter. Institutional investors own 78.53% of the company’s stock.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.